Evolving Changes in Centre-Level Utilization of Longer Distance Donors in Heart Transplantation

Krishna Bhandari1, Khaled Shorbaji1, Akinwale Victor Famotire1

  • 1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC 29425, United States.

Insights

The use of longer distance donors (LDD) in heart transplantation (HT) significantly increased after the 2018 policy change. Survival outcomes for HT recipients using LDD are notably better than with non-LDD, challenging previous assumptions about donor distance and ischemia time.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Public Health Policy

Background:

  • The 2018 allocation policy change aimed to optimize organ utilization in heart transplantation (HT).
  • Understanding the impact of increased donor travel distances on HT outcomes is crucial.

Purpose of the Study:

  • To evaluate changes in the utilization of longer distance donors (LDD) for HT before and after the 2018 policy change.
  • To assess the impact of LDD use on patient survival post-heart transplantation.

Main Methods:

  • Analysis of adult HT recipients (2010-2023) from the United Network for Organ Sharing registry.
  • Trend analysis using the Mann-Kendall test and propensity-matched survival analyses (Kaplan-Meier, restricted mean survival time, Cox models).
  • Comparison of outcomes between LDD and non-LDD recipients, considering donor distance and cold ischemia time.

Main Results:

  • A significant increase in LDD utilization post-2018 policy change, with mean donor distance rising from 171 to 288 miles.
  • Risk-adjusted survival was significantly better for LDD recipients compared to non-LDD recipients at 30-day, 1-year, and 5-year follow-ups.
  • A weak correlation was observed between donor distance and ischemia time in the matched cohort, suggesting distance is not a direct surrogate for ischemia.

Conclusions:

  • The 2018 policy change led to a substantial increase in the use of LDD in heart transplantation.
  • Longer donor distance does not equate to longer ischemia time, and LDD use is associated with improved survival outcomes.
  • Further research is warranted to fully elucidate the benefits and implications of LDD in HT.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495